Search

Your search keyword '"Bernardini, Marcus Q."' showing total 507 results

Search Constraints

Start Over You searched for: Author "Bernardini, Marcus Q." Remove constraint Author: "Bernardini, Marcus Q."
507 results on '"Bernardini, Marcus Q."'

Search Results

51. Data from Microarray Analysis of Early Stage Serous Ovarian Cancers Shows Profiles Predictive of Favorable Outcome

52. Figure S6 from Regulatory T Cells in Ovarian Cancer Are Characterized by a Highly Activated Phenotype Distinct from that in Melanoma

53. Supplemental Figure legends from Regulatory T Cells in Ovarian Cancer Are Characterized by a Highly Activated Phenotype Distinct from that in Melanoma

54. Supplementary Tables S1-S3 from Microarray Analysis of Early Stage Serous Ovarian Cancers Shows Profiles Predictive of Favorable Outcome

55. Supplemental Tables from Regulatory T Cells in Ovarian Cancer Are Characterized by a Highly Activated Phenotype Distinct from that in Melanoma

56. Disturbed sleep is associated with reduced verbal episodic memory and entorhinal cortex volume in younger middle-aged women with risk-reducing early ovarian removal

68. Characteristics and outcome of the COEUR Canadian validation cohort for ovarian cancer biomarkers

69. The optimal time for surgery in women with serous ovarian cancer

70. Leiomyosarcoma

73. Recurrent chromosomal translocations in sarcomas create a megacomplex that mislocalizes NuA4/TIP60 to Polycomb target loci

74. Implementation of a standardized voiding protocol after minimally invasive surgery: A quality improvement initiative

75. Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study

77. Polygenic risk modeling for prediction of epithelial ovarian cancer risk

81. Mucin 13 (MUC13) as a candidate biomarker for ovarian cancer detection: potential to complement CA125 in detecting non-serous subtypes.

84. Factors affecting surgical decision-making in carriers of BRCA1/2 pathogenic variants undergoing risk-reducing surgery at a dedicated hereditary ovarian cancer clinic.

88. A prospective comparison of costs between robotics, laparoscopy, and laparotomy in endometrial cancer among women with Class III obesity or higher

92. The Prevent Ovarian Cancer Program (POCP): Identification of Women at Risk for Ovarian Cancer Using Complementary Recruitment Approaches

93. Performance characteristics of screening strategies for Lynch syndrome in unselected women with newly diagnosed endometrial cancer who have undergone universal germline mutation testing

94. Maximizing cancer prevention through genetic navigation for Lynch syndrome detection in women with newly diagnosed endometrial and nonserous/nonmucinous epithelial ovarian cancer

95. Providers’ perspectives on reproductive decision-making amongst patients carrying a BRCA mutation: a needs assessment

98. Brief family history questionnaire to screen for Lynch syndrome in women with newly diagnosed non- serous, non-mucinous ovarian cancers.

99. Evaluation of treatment effects in patients with endometrial cancer and POLE mutations: An individual patient data meta‐analysis

100. Recurrent chromosomal translocations in sarcomas create a mega-complex that mislocalizes NuA4/TIP60 to Polycomb target loci

Catalog

Books, media, physical & digital resources